Nuform Health Review

What Nuform Health charges

• Tesamorelin: $220 — the per-month figure the page prints beside a prepaid two-month kit — "$220/mo ESSENTIAL package · $440 (2 month plan) · Billed in 2 month increments · DOSED AT 0.5MG FIVE TIMES PER WEEK"; the Elite package at 1 mg is $440/mo, charged as $875 every two months, and the seller states it does not offer monthly prescriptions or subscription plans
• Sermorelin: $160 — the per-month figure printed beside a prepaid four-month kit — "$160/mo large kit · $650 (4 month plan) · Billed in 4 month increments · INCLUDES SUPPLIES"; the small kit is $175/mo charged as $350 every two months, so the cheaper per-month rate is the larger prepayment
• NAD+: $163 — the per-month figure printed beside a prepaid four-month injectable kit — "$163/mo injectable kit · $650 (4 month plan) · Billed in 4 month increments · INCLUDES SUPPLIES"; the page adds "NAD+ is recommended to be taken in 4 month increments"
• NAD+: $90 — the per-month figure printed beside a prepaid two-month oral kit — "$90/mo oral kit · $180 (2 month plan) · Billed in 2 month increments · INCLUDES SUPPLIES"
• Glutathione: $78 — the per-month figure printed beside a prepaid five-month kit — "$78/mo injectable kit · $390 (5 month plan) · Billed in 5 month increments · INCLUDES SUPPLIES"; the whole $390 is charged at once

The seller draws the category line itself

Two of its pages carry a heading asking what research-only peptides are, and answer it. The text says that peptides labelled for research use only, or not for human consumption, are produced by companies that are not subject to quality regulations, and that all of this seller's medications are physician prescribed, come from a licensed United States compounding pharmacy operating under both of the relevant pharmacy categories, are for human use, and are not for research only.

The same pages carry a shorter version above the price block: pharmaceutical-grade medications from licensed United States compounding pharmacies, never research-grade products.

That is a seller declaring its own legal category, in its own words, on the page where it takes the order. Most sellers leave the reader to infer it from a prescription form. This one states it, and states it against the alternative.

What it offers in place of a certificate is a pharmacy class rather than a test result. Those are different assurances and this site does not treat them as interchangeable, but the claim is at least specific enough to check.

A per-month figure attached to something that is not a month

Every peptide here is sold as a kit covering a fixed number of months, and each kit shows two numbers: the total charged and the per-month figure that total divides into. The plan lengths are not uniform — the peptides on this menu run from two-month blocks to a five-month one.

Directly under those figures the site prints its own footnote, which says that to keep treatment consistent and avoid gaps it does not offer monthly prescriptions or subscription plans. So the per-month number is arithmetic the seller has performed for the reader, and the seller says so.

This site records the per-month figure the page prints, marks it as not a monthly rate, and writes the prepaid total and the plan length into the qualifier beside it. A board that sorted this seller by a per-month number without that qualifier would be comparing a division against a bill.

On one compound the longer commitment carries the lower per-month figure and the higher charge. Reading only the smaller of the two numbers on that page gets the more expensive purchase.

A figure next to a compound is not that compound's figure

The research note this row was built from recorded a monthly injectable kit price for this seller's cellular-support compound. Re-reading the page today, that figure is on the page but belongs to a different product block further down, a testosterone and gonadorelin injection, and the compound in question is priced in two entirely different kits.

The correction is recorded on the row itself rather than quietly applied, because the failure is reusable: a long product page stacks unrelated blocks, and a reader — or an extractor — that takes the nearest number to a name will attribute one product's price to another.

The same page publishes both an injectable and an oral version of that compound at different prices and different plan lengths. Both are recorded here, because collapsing them into one figure would hide which route the number belongs to.

Nothing on any page read describes lab work as included at any plan length, and no state coverage list appears anywhere on the site.

Two companies, one brand, and no named pharmacy

The footer names one incorporated company. The terms name a differently-named limited liability company in their heading and a professional corporation alongside it as the clinical practice.

Neither document explains which of those a buyer is contracting with, or which one takes the payment. Two entities behind one storefront is common in this category; leaving the reader to guess which is which is a gap, and it is recorded as a gap rather than resolved by assumption.

The pharmacy is described by its licensing categories and never by name, on any page read. A reader cannot look up the facility that will fill the order.

No certificate of analysis, purity report or third-party testing claim appears in the text of the five pages read. The quality claim here rests entirely on the pharmacy class.

How we verified this

• Loaded five pages on the seller's own host with a full browser user-agent, printed the effective URL beside the requested URL on every fetch, and confirmed no page redirected.
• Ran a nonsense-path control on the same host in the same run and confirmed a not-found response, so a page that answers for any path could not be mistaken for a real one.
• Extracted the visible text with a parser that keeps text nodes only and drops scripts, styles and inline data, then asserted that no markup survived into the extracted text.
• Joined the text nodes before matching any price. This seller splits the currency symbol and the digits across two elements, and a per-node matcher found five figures where the joined text held thirteen — a per-node reading would have reported published prices as absent.
• Bite-tested that price matcher in both directions on a constructed page before using it, and separately confirmed the certificate matcher does not fire on the ordinary English word that contains the same three letters.
• Took every legal-category quotation from the visible body text of the product pages, not from metadata, and reproduced the seller's own spelling.
• Re-read the cellular-support compound's price block in full rather than accepting the figure recorded in the research note, and found that figure belongs to a different product on the same page.
• Searched the extracted text of every page for certificate, purity and third-party testing language and found none, and recorded the character count of each page searched.
• Read the terms page in full for the operating entities rather than taking the first corporate-looking name on the site.